ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "prognostic factors"

  • Abstract Number: 0814 • ACR Convergence 2024

    Rare Variants of PAH Risk Genes Associate with a Distinct Vasculopathy Phenotype and Worse Outcomes in Patients with Systemic Lupus Erythematosus-associated Pulmonary Arterial Hypertension

    Junyan Qian1, Xinzhuang Yang2, Yu Fang Ding3, qian wang1, Jiuliang Zhao1, Weida Liu4, Yongtai Liu5, Zhuang Tian5, Yanhong Wang6, Xiaojian Wang7, Mengtao Li1 and Xiaofeng Zeng8, 1Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China 2National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Beijing, China, 2Center for Bioinformatics, National Infrastructures for Translational Medicine, Institute of Clinical Medicine & Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, 3Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China 2National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, BEIJING, China (People's Republic), 4State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, 5Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China, 6Department of Epidemiology and Biostatistics, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China, 7State Key Laboratory of Cardiovascular Disease, Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China, 8Department of Rheumatology, Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Sciences National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Beijing, China

    Background/Purpose: Systemic lupus erythematosus (SLE)-associated pulmonary arterial hypertension (PAH) displays significant clinical heterogeneity; nevertheless, the underlying mechanisms remain unclear. Presently, more than twenty risk genes…
  • Abstract Number: 2247 • ACR Convergence 2024

    Pro-inflammatory Monocytes and CD11c Expression in ACPA Positive Individuals with Arthralgia and Their Associations with Subclinical Synovitis Preceding the Onset of Arthritis

    Klára Prajzlerová1, Olga Kryštufková2, Petra Hánová1, Nora Růžičková2, Hana Hulejová1, Jiří Vencovský2, Ladislav Šenolt2 and Mária Filková2, 1Institute of Rheumatology, Prague, Czech Republic, 2Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic

    Background/Purpose: Autoantibodies, e.g., against citrullinated proteins (ACPA), increase the risk of clinical arthritis and can be detected years before rheumatoid arthritis (RA) onset. EULAR's definition…
  • Abstract Number: 2665 • ACR Convergence 2024

    Autoantibody Titers Against Specific Epitope Peptides Predict Treatment Resistance in Interstitial Lung Disease Associated with Anti-MDA5 Dermatomyositis

    Tsuneo Sasai1, Ran Nakashima1, Atsubumi Ogawa2, Motohiro Nonaka2, Norimichi Nomura2, Yasuhiro Nohda2, Mirei Shirakashi3, Ryosuke Hiwa2, Hideaki Tsuji1, Shuji Akizuki4, Hajime Yoshifuji1, Tsuneyo Mimori5 and Akio Morinobu6, 1Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, Japan, 2Kyoto University, Kyoto, Japan, 3Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, 4Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto City, Japan, 5Takeda Clinic for Rheumatic Diseases, Kyoto, Japan, 6Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Kyoto, Japan

    Background/Purpose: Anti-melanoma differentiation-associated gene 5 (MDA5)-positive dermatomyositis (DM) is frequently associated with rapidly progressive interstitial lung disease (RP-ILD), leading to poor prognosis. Initial combinational therapy…
  • Abstract Number: 0037 • ACR Convergence 2024

    Clonal Haematopoiesis of Indeterminate Potential (CHIP) Is Associated with Disease Activity in Rheumatoid Arthritis

    Athena Chin1, Sue Branford2, Annabelle Small3, katie Lowe3, malcolm Smith4, Monika Kutyna5, Robert King2, Susanna Proudman6, Devendra Hiwase7 and Mihir Wechalekar8, 1Royal Adelaide Hospital, Tranmere, South Australia, Australia, 2SA Pathology, Adelaide, Australia, 3Flinders University, Adelaide, Australia, 4Flinders Medical Centre, Adelaide, Australia, 5South Australian Health and Medical Research Institute, Adelaide, Australia, 6Royal Adelaide Hospital and University of Adelaide, Medindie, South Australia, Australia, 7Royal Adelaide Hospital, Adelaide, Australia, 8Flinders Medical Centre, Bedford Park, Australia

    Background/Purpose: Clonal haematopoiesis (CH) of indeterminate potential (CHIP) is defined as the detection of recurrent somatic mutations in genes that are known to drive haematological…
  • Abstract Number: 1133 • ACR Convergence 2024

    Relationship Between Nail Psoriasis Severity Index (NAPSI) and Cardiovascular Risk Assessed by Eight Cardiovascular Risk Calculators

    Maria F. Elizondo-Benitez1, Iris Jazmín Colunga Pedraza2, jose Ramon Azpiri-Lopez3, Dionicio Galarza-Delgado4, Jesus Cardenas-de la Garza5, Rosa Icela Arvizu-Rivera2, Andrea Guajardo Aldaco2 and Valeria Gonzalez-Gonzalez6, 1Division of Rheumatology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Nuevo León, Mexico, 2Division of Rheumatology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Mexico, 3Division of Cardiology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Mexico, 4UANL Hospital Universitario, Monterrey, Nuevo León, Mexico, 5Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico, 6Division of Rheumatology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Nuevo León, Mexico

    Background/Purpose: Psoriatic arthritis (PsA) is a chronic, inflammatory, and immune-mediated disease that affects up to 30% of psoriasis (PsO) patients. Nail psoriasis affects 80% of…
  • Abstract Number: 2286 • ACR Convergence 2024

    Certolizumab Inhibits Radiographic Progression Even in RA Patients with High Rheumatoid Factor Levels: A Pooled, Post-Hoc Analysis of Two Phase 3 Trials

    Josef Smolen1, Gerd Burmester2, Yoshiya Tanaka3, Tsutomu Takeuchi4, Jeffrey Curtis5, Ted Mikuls6, Clementina López Medina7, Peter C. Taylor8, Nicola Tilt9, Bernard Lauwerys10, Baran Ufuktepe11 and Thomas Huizinga12, 1Medical University of Vienna, Vienna, Austria, 2Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, Berlin, Germany, 3Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Fukuoka, Japan, 4Department of Internal Medicine, Keio University, Tokyo, Tokyo, Japan, 5The University of Alabama at Birmingham, Birmingham, AL, 6University of Nebraska Medical Center, Omaha, NE, 7Reina Sofia University Hospital, Cordoba, Spain, 8University of Oxford, Oxford, United Kingdom, 9UCB Pharma, Slough, United Kingdom, 10UCB Pharma, Brussels, Belgium, 11UCB Pharma, Istanbul, Turkey, 12Department of Rheumatology, Leiden University, Leiden, Netherlands

    Background/Purpose: In patients (pts) with rheumatoid arthritis (RA), including those treated with disease-modifying antirheumatic drugs, high rheumatoid factor (RF) levels are a poor prognostic factor,…
  • Abstract Number: 2668 • ACR Convergence 2024

    Do Levels of anti-Jo1 Autoantibodies Have a Prognostic Role? Longitudinal Assessment of anti-Jo1 and HisRS Protein Levels in a Cohort of anti-Jo1 Positive Patients with Anti-synthetase Syndrome

    Silvia Cavalli1, Fabricio Espinosa-Ortega2, Ryan A. Adams3, Lauren Guy3, Charlotta Preger4, Càtia Fernandes-Cerqueira5, Roberto Caporali6, Ingrid Lundberg7 and Antonella Notarnicola8, 1University of Milan, Milan, Milan, Italy, 2Division of Rheumatology, Department of Medicine, Solna, Karolinska Institutet; Department of Gastro, Dermatology and Rheumatology, Karolinska University Hospital, Stockholm, Sweden, Stockholm, Stockholms Lan, Sweden, 3aTyr Pharma, 3545 John Hopkins Court, Suite 250, San Diego, CA, 4Division of Rheumatology, Department of Medicine, Solna, Karolinska Institutet;5Structural Genomics Consortium, Stockholm, Sweden, Stockholm, Stockholms Lan, Sweden, 54Dcell, Montrueil, Ile-de-France, France, 6Department of Clinical Sciences and Community Health, University of Milan, and Department of Rheumatology and Medical Sciences, ASST Gaetano Pini-CTO, Milan, Italy, 7Karolinska Universitetssjukhuset, Karolinska Institutet, Stockholm, Sweden, 8Karolinska University Hospital and Karolinska Institutet, Stockholm, Stockholms Lan, Sweden

    Background/Purpose: The anti-Jo1 autoantibody (aJo1), targeting the histidyl-tRNA synthetase (HisRS) protein, is the most common diagnostic biomarker of the anti-synthetase syndrome (ASSD). So far, conflicting…
  • Abstract Number: 0333 • ACR Convergence 2024

    Predictors of Transplant-Free Survival in Idiopathic Inflammatory Myopathies- associated Interstitial Lung Disease

    shiri keret1, Raisa Silva2, Irada Choudhuri2, Eugenia Gkiaouraki3, Tanya Chandra4, Nantakarn Pongtarakulpanit5, shreya Sriram3, silvia Martinez Laverde3, Dana Ascherman3, Siamak Mogahadam5, Chester Oddis5 and Rohit Aggarwal6, 1Rheumatology unit, Bnai-Zion medical center and the faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel., Atlit, Israel, 2Internal medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, 3Division of Rheumatology and Clinical Immunology, University of Pittsburgh Medical Center, Pittsburgh, PA, 4University of Pittsburgh Medical Center, Pittsburgh, PA, 5Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 6Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, USA, Pittsburgh, PA

    Background/Purpose: Lung involvement is the most common and severe extra-muscular manifestation of Idiopathic Inflammatory Myopathies (IIM). Early identification of patients at risk for lung transplant…
  • Abstract Number: 1158 • ACR Convergence 2024

    Microvascular Differences Between Cancer and Non-cancer Anti-transcriptional Intermediary Factor 1 Gamma Antibody (anti-TIF1-γ) Associated Dermatomyositis Patients

    Sehreen Mumtaz1, Megan Sullivan2, Maximiliano Diaz Menindez3, Emily Craver4 and Florentina Berianu5, 1Mayo Clinic, Florida, Jacksonville, FL, 2Mayo Clinic Arizona, Scottsdale, AZ, 3Mayo Clinic School of Graduate Medical Education, Phoenix, AZ, 4Mayo Clinic Florida, Jacksonville, FL, 5mayo clinic, Ponte Vedra Beach, FL

    Background/Purpose: Nailfold videocapillaroscopy (NVC) findings have been studied to differ in different subsets of myositis-specific autoantibodies (MSAs) associated inflammatory myopathies. Prior investigations observed a statistically…
  • Abstract Number: 2297 • ACR Convergence 2024

    Mortality and Its Predictor Variables in Patients with Sjögren Disease: Data from SjögrenSER-Pros Prospective Registry

    Olga Rusinovich1, Zulema Plaza2, Mónica Fernández Castro3, José Rosas-Gómez de Salazar4, Victor Manuel Martinez Taboada5, Alejandro Olive6, Raúl Menor Almagro7, Belen Serrano Benavente8, Judit Font Urgelles9, Angel Garcia-Aparicio10, Sara Manrique-Arija11, Jesus A García-Vadillo12, Ruth Lopez Gonzalez13, Javier Narvaez-García14, Maria Beatriz Rodriguez15, Carlos Galisteo16, Jorge Gonzalez Martin17, Paloma Vela-Casasempere18, Cristina Bohorquez19, MARIA CELIA ERAUSQUIN ARRUABARRENA20, MARIA BEATRIZ PAREDES ROMERO21, ELENA Aurrecoechea22, Sheila Melchor Diaz23, José María Pego-Reigosa24, Sergi Heredia Martin25, Clara Moriano26, Maria Angeles Blazquez Canamero27, Paula Estrada-Alarcón28, enrique Judez29, Joaquin María Belzunegui:30, Consuelo Ramos31, Marta de la Puerta32, Fernando Sánchez-Alonso33 and Jose Luis Andreu34, 1Hospital Universitario Puerta de Hierro Majadahonda., Boadilla del Monte, Spain, 2Fundacion Española de Reumatología, Madrid, Spain, 3Hospital Universitario Puerta de Hierro Majadahonda., Madrid, Madrid, Spain, 4Hospital Marina Baixa, PALMA DE MALLORCA, Comunidad Valenciana, Spain, 5Facultad de Medicina. Universidad de Cantabria, Santander, Cantabria, Spain, 6Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain, 7Department of Rheumatology, Hospital Jerez de la Frontera, Jerez de la Frontera, Spain, 8Hospital Gregorio Marañón, Madrid, Madrid, Spain, 9Hospital Universitari Germans Trias i Pujol, Badalona, Spain, 10Hospital Universitario de Toledo, Toledo, Spain, 11Biomedical Research Institute of Malaga (IBIMA)-Bionand Platform, Department of Rheumatology, Regional University Hospital of Malaga, Malaga, Spain, 12H La Princesa, Madrid, Spain, 13Complejo Hospitalario de Zamora, Zamora, Castilla y Leon, Spain, 14Hospital Universitario de Bellvitge, Barcelona, Spain, 15H Universitario de Canarias, La Laguna- Tenerife, Canarias, Spain, 16Hospital Universitario Parc Taulí, Sabadell, Spain, 17H Madrid Norte SanChinarro, Madrid, Spain, 18Hospital General Universitario Alicante, Alicante, Spain, 19Hospital Universitario Príncipe de Asturias, Alcalá De Henares, Madrid, Spain, 20Gob Canarias, Tenerife, Canarias, Spain, 21H Infanta Sofia, Madrid, Spain, 22HOSPITAL SIERRALLANA, CANTABRIA, Spain, 2312 de Octubre University Hospital, Madrid, Spain, 24Galicia Health Service (SERGAS), Vigo, Spain, 25Hospital de L’Hospitalet, Barcelona, Spain, 26Hospital León, LEON, Spain, 27Hospital Ramon y Cajal, Madrid, Madrid, Spain, 28Hospital de San Juan Despí Moisès Broggi, Barcelona, Spain, 29H de Albacete, Albacete, Spain, 30H de Donostia, Donostia-San Sebasti, Spain, 31Hospital Universitario Virgen de Valme, Sevilla, Spain, 32Spanish Society of Rheumatology, Madrid, Spain, 33Sociedad Española de Reumatología, Madrid, Spain, 34Hospital Universitario Puerta de Hierro Majadahonda., Majadahonda, Spain

    Background/Purpose: It remains debated if patients with Sjögren´s disease (SjD) have a greater mortality risk. The objective of our study was to determine the magnitude…
  • Abstract Number: 0479 • ACR Convergence 2024

    Constructing and Using a Novel Nucleotide Transformer for Patients with Rheumatoid Arthritis

    Shant Ayanian, Collin Osborne, Marc Blasi, Daniel Darveaux, Eric Klee and Elena Myasoedova, Mayo Clinic, Rochester, MN

    Background/Purpose: Applying the methods of artificial intelligence (AI) to genomic data for clinical outcome prediction in rheumatoid arthritis (RA) is an area of growing research.…
  • Abstract Number: 1202 • ACR Convergence 2024

    Harnessing MicroRNA and Machine/Deep Learning for Early Prediction of Knee Osteoarthritis Structural Progression

    Afshin Jamshidi1, Osvaldo Espin-Garcia2, Thomas G. Wilson3, Ian Loveless3, Jean-Pierre Pelletier1, Amanda Ali4 and Johanne Martel-Pelletier1, 1Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), Montreal, QC, Canada, 2Department of Epidemiology and Biostatistics, University of Western Ontario; Dalla Lana School of Public Health and Department of Statistical Sciences, University of Toronto; Department of Biostatistics, Schroeder Arthritis Institute; Krembil Research Institute, University Health Network, Toronto, ON, Canada, 3Henry Ford Health + Michigan State University Health Sciences, Detroit, MI, 4Henry Ford Health + Michigan State University Health Sciences; Center for Molecular Medicine and Genetics, Wayne State University, Montreal, QC, Canada

    Background/Purpose: The development of knee osteoarthritis (OA) is generally characterized by a slow evolution. However, its progression and severity may occur rapidly in some individuals.…
  • Abstract Number: 2379 • ACR Convergence 2024

    Causal Proteomics-Assisted Machine Learning Model Enhances Flare Risk Prediction in Systemic Lupus Erythematosus

    Liying Chen1, Ou Deng2, Ruichen Cong2, Dingqi Lu3, Ting Fang1, Mei Chen1, Runrun Zhang4 and Xinchang Wang3, 1Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, China (People's Republic), 2Graduate School of Human Sciences, Waseda University, Mikajima, Japan, 3Department of Rheumatology, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China (People's Republic), 4The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China (People's Republic)

    Background/Purpose: Objectives: Systemic lupus erythematosus (SLE) is an autoimmune disease marked by unpredictable flares. However, no flare risk prediction model has been developed for Asian…
  • Abstract Number: 0496 • ACR Convergence 2024

    Dissecting Early RA Patient Trajectories Through Time-independent Disease State Identification Identifies Distinct Patterns Dissected by Inflammation in Blood or Joints

    Nils Steinz1, Tjardo Maarseveen2, Andrew Cope3, John Isaacs4, Aaron Winkler5, Thomas Huizinga6, Yann Abraham7 and Rachel Knevel1, 1Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Department of Rheumatology, Leiden University Medical Center, Wormerveer, Netherlands, 3King's College London, London, United Kingdom, 4Translational and Clinical Research Institute, NIHR Newcastle Biomedical Research Centre, Newcastle University and The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom, 5Pfizer Inc., Cambridge, MA, 6Department of Rheumatology, Leiden University, Leiden, Netherlands, 7Janssen Research and Development, Beerse, Belgium

    Background/Purpose: Patients with RA display different trajectories in the improvement of disease activity. Discerning the RA trajectories, how they differ between patients and which factors…
  • Abstract Number: 1245 • ACR Convergence 2024

    Inpatient Discontinuation of Allopurinol – A Quality Improvement (QI) Initiative

    Stephanie Tancer1, Basmah Al Dulaijan2 and Puja Khanna3, 1University of Michigan Department of Internal Medicine, Division of Rheumatology, Ann Arbor, MI, 2Michigan Medicine, Ann Arbor, MI, 3University of Michigan, Ann Arbor, MI

    Background/Purpose: Gout is a chronic inflammatory arthritis induced by hyperuricemia and manifested by recurrent acute flares of debilitating joint pain when left untreated. Allopurinol is…
  • 1
  • 2
  • 3
  • …
  • 18
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology